Prognostic Value of Alkaline Phosphatase and Gamma-Glutamyl Transferase in Patients with Metastatic Pancreatic Cancer

Martina Catalano, Giandomenico Roviello, Giuseppe Aprile, Monica Ramello, Raffaele Conca, Roberto Petrioli, Gabriele Perrone, Anna Ianza, Enrico Mini

Future Oncology · 2023 · 15 citations · 45 references

Concepts

Abstract

Background: Pancreatic cancer (PC) is one of the most lethal malignancies worldwide. This study evaluated the prognostic role of serum alanine phosphatase (ALP) and gamma-glutamyl-transferase (GGT) in metastatic PC patients. Materials & methods: 153 patients with metastatic PC receiving first-line treatment with nab-paclitaxel/gemcitabine were retrospectively enrolled in a multicenter study and stratified according to ALP (≤ or >260 U/l) and GGT (≤ or >45.5 U/l) levels. Results: Improved overall survival was recorded in patients with GGT levels ≤45.5 U/l (p < 0.05). In patients with liver metastasis, overall survival was significantly lower in patients with high ALP (p = 0.01) and GGT (p = 0.02). Conclusion: High levels of ALP and GGT were related to a poor prognosis in PC patients with liver metastasis receiving nab-paclitaxel/gemcitabine.

References

45